Prolira BV is a high-tech research and development SME and spin-off from the University Medical Center Utrecht, the Netherlands. The company's device, deltaScan, measures brain signals from the patient through electrodes incorporated in a headband, and displays the results in a portable monitor. The device enables patients, nurses, physicians, and hospitals to tackle delirium at the source through timely treatment, thereby improving detection and monitoring. Prolira BV has a management team consisting of two founders who lead a technical team, a market introduction team, and a clinical evaluation team. The company is supported by an advisory board and an international clinical evaluation board consisting of three leading academic medical centers in Europe.